POPULARITY
Categories
Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. Tired of staring into the fridge exhausted, hungry, and out of ideas?Enter Brooke Simonson, a nutrition and mindset coach who specialises in helping busy women eat well without the all-or-nothing approach. She supports my clinic every month through group calls and my 30/30 Program, so she sees firsthand what people are up against (and what actually works in the thick of real life).We cover simple, practical tools you can use straight away, including her weekly high-protein lunch rotation, the “home menu” strategy to reduce decision fatigue, fibre go-tos that actually help, and a quick label-check hack for choosing higher-protein, higher-fibre foods at the grocery store. Hit play to simplify meal prep and feel confident you're eating well, even on the most chaotic days!ReferencesConnect with Brooke:WebsiteInstagram TikTokThe 30/30 ProgramAudio Stamps01:04 - Meet Brooke Simonson, nutrition coach and mindset expert who helps clients break the crash diet cycle.04:36 - The genius high-protein lunch rotation that eliminates decision fatigue on busy days.11:24 - Why creating a personal menu solves the "I don't know what to eat" panic.14:25 - Brooke's go-to foods for hitting protein and fiber goals effortlessly.21:20 - How to make one meal work for the whole family without becoming a short-order cook.23:10 - How to eat well during your busiest seasons without relying on takeout or processed foods.32:06 - Simple tricks for identifying the most nutrient-dense foods at the grocery store.All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com Not Sure Where to Start With the Podcast? I've Got You.Get my free Podcast Roadmap—a simple guide to help you find the episodes that matter most to your journey. Whether you're on GLP-1s, navigating plateaus, or just starting out, there's something here for you.Support the show
Peripheral Neuropathy: Causes, Symptoms, And New Treatment Options When nerves lose the energy they need to function, it leads to numbness, pain, and loss of mobility for millions of Americans. New research is uncovering how risk factors like obesity, high blood pressure, and food insecurity disproportionately affect certain communities. As scientists work to refine treatments and explore promising therapies that include GLP-1 medications, early detection, dietary changes, and improved access to healthcare remain critical to stopping the progression of this condition. How Improving Healthcare For People With Disabilities Helps Everyone Special Olympics is working to close major gaps in healthcare for people with intellectual and developmental disabilities. A new global report reveals widespread problems – from poor provider training to communication barriers – that prevent individuals with IDD from receiving informed, respectful, and effective care. The organization hopes to create a more inclusive system by improving physician training and empowering people with IDD to participate in their own health decisions. Medical Notes: We're Overusing Salt, How Feeding Birds Improves Our Quality Of Life, And Protecting Kids From HIV How can we save babies born with HIV? We're overusing salt – and not just in our pasta. Technology is only as good as it's creator. Is it time to invest in a bird feeder? Learn more about your ad choices. Visit megaphone.fm/adchoices
Larry is joined by podcast host Jon Lovett for a wide-ranging conversation on the current state of the world. They discuss Trump, Democratic frontrunners, health care, Lovett's personal experience with GLP-1 medications, and much more. Host: Larry WilmoreGuest: Jon LovettProducers: Devon Renaldo and Brandy LaPlante Learn more about your ad choices. Visit podcastchoices.com/adchoices
“If you really want to be strong and you want to do strength training, you need to eat carbohydrates,” explains Ana Kausel, M.D. Ana Kausel, M.D., a board-certified endocrinologist and women's health expert, joins us today to share how women can build metabolic strength from the inside out—through muscle, nutrition, hormones, and lifestyle. - Her experience gaining 9 lbs of muscle (~3:40) - GLP-1 dosage (~6:10) - The importance of lifestyle on GLP-1s (~6:45) - Her approach to training (~11:00) - Balancing fat & protein (~14:15) - Increasing protein intake (~17:00) - The role of carbs (~17:30) - Improving metabolic health (~19:00) - Creatine & taurine (~21:00) - Testing female hormones (~22:15) - Symptoms vs. lab work (~23:45) - HRT: Compounding vs. bioidentical (~27:40) - Her take on DHEA (~28:45) - Testosterone levels (~31:15) - Use cases of GLP-1s (~35:55) - Her nutrition philosophy (~37:20) - Are NAD supplements worth it? (~47:25) - The importance of calcium (~48:00) Referenced in the episode: - Follow Kausel on Instagram (@dranakausel) - Check out her YouTube (https://www.youtube.com/@DraAnaKausel) - Work with her (https://anzarahealth.com/) This podcast was made in partnership with Gaia Herbs. Your path to stress support starts now.* Visit gaiaherbs.com and use promo code MBGPod to get 20% off. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
When nerves lose the energy they need to function, it leads to numbness, pain, and loss of mobility for millions of Americans. New research is uncovering how risk factors like obesity, high blood pressure, and food insecurity disproportionately affect certain communities. As scientists work to refine treatments and explore promising therapies that include GLP-1 medications, early detection, dietary changes, and improved access to healthcare remain critical to stopping the progression of this condition. Learn more about your ad choices. Visit megaphone.fm/adchoices
Millions have experienced incredible weight loss using GLP-1 medications. But many are now facing the next chapter of the story… what I'm calling Life After GLP-1s. Today, I'm going to give you the COMPLETE science-backed roadmap for keeping the weight off naturally — without injections, without breaking the bank……and without fear.So let's get into it.Let's start with the big fear on everyone's mind: “What if the weight just comes right back?”
Die "Abnehmspritze" ist gerade überall: in den Medien, in Social Media und in unzähligen Gesprächen - als wäre sie die schnelle Antwort auf ein Thema, das in Wahrheit viel komplexer ist. Rund um GLP-1-Agonisten ist ein riesiger Markt entstanden, viele Menschen nehmen sie bereits, doch die wenigsten wurden wirklich verständlich und sauber aufgeklärt: Was sind diese Medikamente eigentlich, wofür wurden sie entwickelt, wie funktionieren sie und was bewirken sie im Körper wirklich? In dieser Podcast-Folge bringe ich, zusammen mit Holger Gugg, Ordnung in den Hype, ohne zu moralisieren und ohne eine Seite einzunehmen. Du erfährst medizinisch fundiert und alltagstauglich erklärt, warum GLP-1-Agonisten nicht "Fett wegzaubern", sondern vor allem über Sättigung, Appetitregulation und Veränderungen im Verdauungssystem wirken, weshalb sich dadurch Essen anders anfühlen kann und warum Nebenwirkungen wie Übelkeit oder Magen-Darm-Beschwerden ein relevantes Thema sind. Vor allem geht es mir darum, dass Du nach der Folge nicht nur eine Meinung hast, sondern ein echtes Verständnis, denn erst dann kannst Du entscheiden, ob so ein Weg für Dich überhaupt infrage kommt. Und ganz wichtig: Selbst wenn ein Medikament unterstützt, bleibt nachhaltiger Erfolg fast immer an den Lebensstil gekoppelt. Ernährung, Krafttraining und ein alltagstaugliches System entscheiden darüber, ob Du Dich am Ende wirklich stärker, fitter und stabiler fühlst oder ob es nur ein kurzfristiger Effekt bleibt. Wenn Du Dir dabei Begleitung wünschst und nicht alleine herumprobieren willst, dann melde Dich bei mir für mein Performance Coaching. Melde dich gerne zu einem kostenfreien Kennenlerngespräch an und wir schauen gemeinsam, wo Du stehst und wie Dein Plan aussehen kann, der wirklich zu Deinem Leben passt. https://andreas-trienbacher.com/coaching/ __________________________
If you're menopausal and on a GLP-1 medication or peptide (semaglutide, tirzepatide, compounded peptides, microdosing, etc.), this is one of the most important videos you'll ever watch. Most women make the SAME mistake…
Agradece a este podcast tantas horas de entretenimiento y disfruta de episodios exclusivos como éste. ¡Apóyale en iVoox! Acceso anticipado para Fans - Hoy en La Gran Travesía, con motivo del cumpleaños de Mike Scott (14 de diciembre de 1958), recuperamos la discografía de su banda, los Waterboys. También recordaros que ya podéis comprar La gran travesía del rock, un libro interactivo. Jimi y Janis, dos periodistas musicales, vienen de 2027, un mundo distópico y delirante donde el reguetón tiene (casi) todo el poder... pero ellos dos, deciden alistarse al GLP para viajar en el tiempo, salvar el rock, rescatar sus archivos ocultos y combatir la dictadura troyana del FPR. ✨ El libro ya está en diversas tiendas, Amazon, Fnac y también en La Montaña Mágica, por ejemplo https://www.amazon.es/GRAN-TRAVES%C3%8DA-DEL-ROCK-autoestopista/dp/8419924938 ▶️ Y ya sabéis, si os gusta el programa y os apetece, podéis apoyarnos y colaborar con nosotros por el simple precio de una cerveza al mes, desde el botón azul de iVoox, y así, además podéis acceder a todo el archivo histórico exclusivo. Muchas gracias también a todos los mecenas y patrocinadores por vuestro apoyo: Daen Cho, Diego Román, Tole, Raquel, Poncho C, Contell Carles, Sergio Rodríguez Rojas, Javier, Jose Antonio Moral, Juanito, Octavio Oliva, Andreea Deea, Samuel Sánchez, Igor Gómez Tomás, Matías Ruiz Molina, Eduardo Villaverde Vidal, Víctor Fernández Martínez, Rami, Leo Giménez, Alberto Velasco, Poncho C, Francisco Quintana, Con, Tete García, Jose Angel Tremiño, Marco Landeta Vacas, Oscar García Muñoz, Raquel Parrondo, Nacho, Javito, Alberto, Moy, Dani Pérez, Santi Oliva, Vicente DC, Leticia, Melomanic, Arturo Soriano, Gemma Codina, Raquel Jiménez, Pedro, SGD, Raul Andres, Tomás Pérez, Pablo Pineda, Quim Goday, Enfermerator, Joaquín, Horns Up, Victor Bravo, Fonune, Francisco González, Marcos Paris, Daniel A, Redneckman, Elliott SF, Sementalex, Miguel Angel Torres, Suibne, Noyatan, Iván Menéndez, Niksisley y a los mecenas anónimos.Escucha este episodio completo y accede a todo el contenido exclusivo de La Gran Travesía. Descubre antes que nadie los nuevos episodios, y participa en la comunidad exclusiva de oyentes en https://go.ivoox.com/sq/489260
Broadcast from KSQD, Santa Cruz on 12-11-2025: Dr. Dawn presents colleague Dr. Paul Godin's essay on why US healthcare fails as a market system . She explains that healthcare violates every assumption of functional markets: patients can't compare options during emergencies, information asymmetry prevents informed decisions, demand is inelastic when one has an urgent medical issue, and trust is essential to medicine and in direct conflict with profit incentives. Since 1988's Knox-Keen Act allowed for-profit healthcare, private equity has acquired and stripped hospitals, while administrative costs consume enormous resources fighting over payments rather than providing care. She contrasts this with European models like Switzerland and Germany where everyone must participate, insurers must accept all patients, and profit on basic coverage is limited. She celebrates a vaccination success story: HPV vaccines have reduced cervical cancer by 50% over 30 years. The American Cancer Society now endorses self-collected vaginal samples for HPV screening, with an FDA-approved at-home kit from Teal Health allowing women to skip speculums and traditional Pap smears. Current guidelines recommend screening starting at age 25, with testing every five years after a negative result. Dr. Dawn issues a health alert about multiple hospitalizations in Santa Cruz County from foraged wild mushrooms identified incorrectly by phone apps. She describes cholinergic toxicity symptoms: sweating, excessive salivation, pinpoint pupils, and abdominal cramping—signs requiring immediate emergency care rather than waiting it out. She offers follow-up vaccine advice: "go in wet, then sweat." Hydrate before vaccination, then take a hot Epsom salt bath until sweat runs off your face. This helps eliminate adjuvants that cause post-vaccine fatigue and aches, which are often misinterpreted as catching illness from the vaccine itself. Dr. Dawn expresses alarm that Kennedy's reconstituted ACIP nearly voted to eliminate hepatitis B vaccination at birth. She notes infants exposed to infected mothers have 99% infection rates, with half becoming chronically infected and half of those developing terminal cirrhosis or cancer. Testing pregnant women misses infections acquired during pregnancy, and 12-16% of delivering women have no test records. Major insurers have committed to covering birth vaccination through 2026 despite the panel's actions. She offers holiday microbiome advice from researcher Karen Corbin: increase fiber intake through steel-cut oats, whole grain breads like Dave's Killer Bread, beans, apples, and alternative pastas made from lentils or garbanzo beans. Cooking potatoes ahead and reheating creates resistant starch that feeds beneficial gut bacteria, reduces inflammation, and even stimulates natural GLP-1 production. Dr. Dawn reviews research proving health insurance saves lives. When the ACA's Medicaid expansion became optional by state, researchers could compare outcomes, finding 8% lower mortality and 19,000 fewer deaths in expansion states over four years. An accidental IRS experiment—sending insurance enrollment letters to only 85% of penalty payers—showed significantly lower mortality among those who subsequently got insured. Studies of gunshot and auto accident victims found uninsured patients died more often despite receiving identical emergency treatment. She concludes with surprising cancer symptoms: chest pain specifically triggered by alcohol consumption may indicate Hodgkin's lymphoma, as vasodilation activates inflammatory chemicals in affected lymph nodes. Fractures from minimal trauma in people without osteoporosis warrant investigation, as 5% of cancers involve bone. Elevated calcium levels double cancer diagnosis risk in the following year and should prompt follow-up testing.
https://www.otplinks.com 0:00 Welcome & today's focus: Retatrutide and “chasing the biggest number” 1:11 On The Pen intro, live schedule (Mon/Wed/Fri) & housekeeping 2:10 How Dave first heard about retatrutide (work trip, early phase 1 data) 3:35 Flashback clip: early excitement about retatrutide phase 3 trials 4:40 Why this new retatrutide data feels different for obesity medicine 5:32 TRIUMPH-4 trial overview: obesity + knee osteoarthritis population 7:00 Headline results: 28.7% average weight loss, surgery-level efficacy 8:47 Breaking down weight loss by dose (9 mg vs 12 mg; 25–35% loss rates) 11:05 What “efficacy estimate” really means (race-track analogy) 13:28 Real-world view: treatment-regimen estimate (20–23.7%) vs trial ideal 15:40 Mechanism refresher: GIP, GLP-1, glucagon and why RETA differs from TIRZ 18:05 Side effects, dysesthesia/allodynia & who stopped treatment (BMI differences) 21:02 Why the lower doses matter & who actually needs 30% weight loss 24:15 From “just make the scale go down” to quality of weight loss & body composition 28:05 Future focus: health, longevity, and peptides beyond hitting goal weight 30:40 Viewer Q&A: combining RETA + TIRZ, amylin (eloralintide) combos & “talk to your doctor” 34:38 How retatrutide changes the next decade of obesity treatment conversations 37:22 News update: high-dose Wegovy 7.2 mg approval in the EU & US outlook 40:55 Orforglipron oral GLP-1: liver-signal concerns & fast-track FDA review 45:20 Why small-molecule oral GLP-1s aren't the same as injectable peptides 48:40 New topic: Indiana “Safe Drug Act of 2025” and why Dave is concerned 51:02 Production caps, “essentially a copy” language & shifting power from prescribers to FDA 54:28 How the bill undermines personalization while ignoring real safety tools 57:05 Safety theater vs real safeguards: API sourcing, sterility & adverse-event reporting 59:45 Who actually gets hit: compliant 503A/503B compounders vs existing bad actors 1:02:05 Call to action: petition at otplinks.com & why patient voices matter 1:05:10 Change.org impact, media attention & centering the patient perspective 1:07:30 Final Q&A, subscribe, obesity.news email list & closing thanks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
This episode features Dr. Pinkston and Paul Herchman, Co-Executive Founder of Get Hair MD, discussing a holistic and evidence-based approach to hair loss. They highlight the widespread issue of hair loss in both men and women, exacerbated by factors like stress and rapid weight loss (including GLP-1s). Key Takeaways from Get Hair MD's Approach: Multifactorial Treatment: Hair loss is complex, requiring a comprehensive approach. Personalized Diagnosis: The process begins with an AI-driven photo documentation system to identify viable hairs, followed by a cheek swab for genetic analysis. This determines which topical products (like Minoxidil) a patient can effectively metabolize, avoiding wasted time and money. Treatment Modalities: Low-Level Laser Therapy (LLLT): A Class II device used to quickly stop hair loss and is often done in-office a couple of times a month initially. HairCell Technology: A new, exciting technology that uses electrical stimulation to signal cells to emit beneficial proteins like Clotho (longevity protein) and COAL17A (hair longevity protein) to condition the atrophic scalp. Topical & Oral Supplements: Customized topical sprays from compounding pharmacies, plus validated vitamins and specialized shampoos. Regenerative Products: Physicians may use extracellular matrix/regenerative products like exosomes, often applied using needle-free technology for comfort. Sustained Home Care: Patented dual-wavelength caps are used at home to maintain results and protect the investment. They also offer a protective, fashionable baseball cap that filters sun to SPF 50 while converting sun rays to a therapeutic wavelength. Early Intervention is Key: The most important message is to act early. Once a hair follicle dies, it cannot be reversed. Don't waste time and money on unproven methods. https://gethairmd.com/ See omnystudio.com/listener for privacy information.
Guest Suggestion Form: https://forms.gle/bnaeY3FpoFU9ZjA47Disclaimer: This video is intended solely for educational purposes and opinions shared by the guest are her personal views. We do not intent to defame or harm any person/ brand/ product/ country/ profession mentioned in the video. Our goal is to provide information to help audience make informed choices. The media used in this video are solely for informational purposes and belongs to their respective owners.Order 'Build, Don't Talk' (in English) here: https://amzn.eu/d/eCfijRuOrder 'Build Don't Talk' (in Hindi) here: https://amzn.eu/d/4wZISO0Follow Our Whatsapp Channel: https://www.whatsapp.com/channel/0029VaokF5x0bIdi3Qn9ef2JSubscribe To Our Other YouTube Channels:-https://www.youtube.com/@rajshamaniclipshttps://www.youtube.com/@RajShamani.Shorts
Week 15 in the NFL is here with a fury and it has quite the lineup. Multiple games with playoff implications, a few games that could clinch a playoff spot for certain teams and a couple do or die matchups. Our game of the week is the New England Patriots vs the Buffalo Bills. Will Drake Maye and Mike Vrabel sweep the Bills or does Josh Allen play superhero ball two weeks in a row? A matchup we see as a potential Super Bowl matchup is the Green Bay Packers vs the Denver Broncos - does Toyotathon Love come out on top in the Mile High City? The Lions, Chiefs and Colts all look to stay alive in the playoff race while the Bears and Eagles look to avoid a second tumble in as many weeks. All eyes are on Philip Rivers, will he play and how will he perform? The fellas end with a very special Cardinals-Texans ad men, the Bermuda Triangle game of Commanders vs Giants, Thursday Night Time Machine and a very important announcement regarding the Monday Live show. (00:00:00) - NFL Week 15 Previews (00:17:15) - Buffalo Bills at New England Patriots (00:26:05) - Green Bay Packers at Denver Broncos (00:40:42) - Detroit Lions at LA Rams (00:53:57) - Indianapolis Colts at Seattle Seahawks (01:06:05) - LA Chargers at Kansas City Chiefs (01:12:49) - Cleveland Browns at Chicago Bears (01:25:25) - Las Vegas Raiders at Philadelphia Eagles (01:33:42) - Houston Texans at Arizona Cardinals (01:42:08) - New Orleans Saints at Carolina Panthers (01:43:27) - Tennessee Titans at San Francisco 49ers (01:44:09) - Baltimore Ravens at Cincinnati Bengals (01:55:35) - New York Jets at Jacksonville Jaguars (01:56:16) - Bermuda Triangle Game: Washington Commanders at New York Giants (02:02:00) - TNTM (02:04:10) - GLP's Monday Live Stream Announcement For the NFL's My Cause My Cleats, visit these sites to support:https://mcmc.rayzeapp.com/beauallen http://strongerthanyouthink.org/ Have some interesting takes, some codebreaks or just want to talk to the Green Light Crew? We want to hear from you. Call into the Green Light Hotline and give us your hottest takes, your biggest gripes and general thoughts. Day and night, this hotline is open. Green Light Hotline: (202) 991-0723 Also, check out our paddling partners at Appomattox River Company to get your canoes, kayaks and paddleboards so you're set to hit the river this summer. Green Light's YouTube Channel, where you can catch all the latest GL action: If you want some Black Friday merch, check out our sale:https://greenlightpodcast.shop/?fbclid=PAZnRzaAOR1RFleHRuA2FlbQIxMQBzcnRjBmFwcF9pZA8xMjQwMjQ1NzQyODc0MTQAAad3Jup6i1N2qH77pK8eUeSbKt2Y0OXMldIw1dRTq_xDRuY3Ctp99Qj4pfyGAw_aem_w9tp_XwGL-ZptFIHvlrM1g Green Light with Chris Long: Subscribe and enjoy weekly content including podcasts, documentaries, live chats, celebrity interviews and more including hot news items, trending discussions from the NFL, MLB, NHL, NBA, NCAA are just a small part of what we will be sharing with you.
In this episode, Dr. Thomas Hemingway will share the Secret to Not Gaining Weight over the Holidays, yet still Enjoy them to the Fullest!Have a Listen and SHARE with a friend!**JOIN DR. HEMINGWAY LIVE in-person at ALIGN AWAKEN! Event in San Diego Jan 22-25, 2026!*ACCESS my FREE workshop, "Younger, Stronger, for Longer!" How to turn back your biological age 10-20 years so you can do the things you want to do that you no longer thought possible due to your age. Perform at your best and live your best life!*And, in my new Performance, and Longevity medical practice we specialize in turning back your biological age and OPTIMIZING HORMONES so you can feel a decade or more younger so you can do the things you want to do that you thought were no longer possible due to your age. Join the waitlist here!*SHARE with a Friend and please drop a Review:)*Don't wait to Prioritize your health, Start Today with the Simple and Powerful Steps detailed in my Best-selling book.*GET DIRECT ACCESS to DR. HEMINGWAY in these AMAZING COURSES!**Free resource: 'The truth about GLP-1s and their alternatives' - https://drthomashemingway.myflodesk.com/n1yyjkcb68Mahalo and Aloha andTo your health,
Are you feeling crushed by the pressure to lose weight? You’re not alone. In this honest and compassionate episode, Heather Creekmore tackles the overwhelming desire so many women carry to lose weight—even when we know the struggle all too well. Heather Creekmore dives deep into the real reasons why our culture is fixated on shrinking our bodies, the rise of GLP-1 medications like Ozempic, and what it means now that nearly 1 in 5 adults in the US have tried these weight-loss shots. Whether you use them, are considering them, or tried them and now feel even more burned by diet culture, this episode is for you. What you’ll hear in this episode: Why so many of us feel pressured to be thinner, especially during the holiday season How body image struggles are magnified by social media, holiday events, and cultural expectations What the Gospel teaches us on humility, worth, and where our true value is rooted (hint: it’s not in the scale or in being the “thinnest one in the photo”) Real talk about the cost—mentally, physically, and spiritually—of making weight loss your primary goal Encouraging reminders that your struggle is not a “you problem,” but a symptom of a wider issue in our society Practical steps for what to do when the desire to lose weight feels overwhelming If you’re tired of wrestling with disappointment from the latest weight loss trends, or you need encouragement to find freedom from the idol of body image, tune in for wise, compassionate truth that will point you to lasting hope. Special Invitation:Ready for a new way—one that invites more freedom, less comparison, and true worth? Don’t miss the announcement about the next 40-Day Body Image Journey (starts January 20th)! Head to improvebodyimage.com to learn more. Share this episode with a friend or leave a review if it encourages you—your support helps others find hope and healing too. Stop comparing. Start living. Listen now to “When the Want to Lose Weight Is Overwhelming” on Compared to Who? Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.
Send a Text Message. Please include your name and email so we can answer you! Please note, this does not subscribe you to our email list, it's just to answer if you have a questions for us. This week's Friday Five tackles a question many women quietly wonder about: “What should I expect if I restart Mounjaro after pregnancy and breastfeeding?”Whether you paused your GLP-1 for pregnancy, breastfeeding, or simply life circumstances, coming back to it after many months brings up a lot of unknowns. In this episode, I break down what typically happens, what we actually know from emerging research, and most importantly—why postpartum women need close, compassionate medical support.Inside the episode, we explore:1. What current guidelines say about GLP-1s, pregnancy, and breastfeedingThe traditional recommendation is stopping GLP-1s two months before trying to conceive and waiting until you're done breastfeeding to restart. But I also share a recent small study looking at semaglutide and its transfer into breast milk—and what that means (and doesn't mean) for real-life decisions.2. Why restarting after long-term use often looks differentIf you were previously on Mounjaro for 6–24 months, your body typically:tolerates the medication more easilycan often titrate up more quicklyexperiences fewer early side effects Some of this is physiologic, some behavioral—because you've already learned hydration, fiber strategies, and the day-after-injection do's and don'ts.3. The postpartum period is the “fourth trimester”—and it changes everythingExhaustion, unpredictable schedules, stress, hormones, sleep deprivation… postpartum is not just a season. It's a vulnerable season. This is why you should never “go cowboy alone” when restarting medication. A skilled clinician helps prevent:excessive restrictionmetabolic overwhelmworsening moodtipping into depression or anxietyextreme titration that backfires4. How ongoing support during pregnancy impacts your restartI share examples from my own clinic: Some women stay with me through pregnancy—not for weight loss, but for structure, nutrition support, and a stable relationship with food. Those women often find it much easier to restart postpartum because they never disconnected from caring for their bodies.5. The good news: most women feel relief when they restartOnce medically cleared and supported, many women say:their appetite becomes manageable againtheir mental load decreasestheir urges and cravings quiet downthey finally feel like they have helpAnd that's the whole point: to feel supported, not stressed.If you're in this season, I'm rooting for both your health and your baby's health. Postpartum is not a time to go it alone, and you deserve expert guidance every step of the way.I hope this episode gives you clarity, comfort, All of the information on this podcast is for general informational purposes only. Please talk to your physician and medical team about what is right for you. No medical advice is being on this podcast. If you live in Indiana or Illinois and want to work with doctor Matthea Rentea, you can find out more on www.RenteaClinic.com Health is the best gift you can give. Select ‘Give as a gift' at checkout to share one of our programs with someone you love. Explore the details here.Support the show
Your taxes could be going up. City Council and Pittsburgh Public Schools both officially proposed increases for next year. Host Megan Harris, executive producer Mallory Falk, and producer Sophia Lo explain how we got here and how much extra you might be paying if the tax hikes do, in fact, get approved. Plus, they discuss a new direct flight to one of Pittsburgh's favorite places, new state restrictions on GLP-1 drugs, the Terrible Towel's big milestone birthday, and your final opportunity to snag an exclusive City Cast Pittsburgh beanie. Get more from City Cast Pittsburgh when you become a City Cast Pittsburgh Neighbor. You'll enjoy perks like ad-free listening, invitations to members only events and more. Join now at https://membership.citycast.fm Request a song for our holiday show! Call or text the HOLIDAY HOTLINE at 412-212-8893. Notes and references from today's show: Our Ultimate Pittsburgh Gift Guide [City Cast Pittsburgh] PODCAST: 'Sloppy' City Budget, Zombie Studies & Giant Eagle vs. Everybody [City Cast Pittsburgh] Same budget, different universes: Pittsburgh council, mayor diverge on 2026 spending plan [TribLive] Pittsburgh City Council grapples with competing narratives surrounding budget [P-G] Sharply contrasting views of Pittsburgh budget emerge ahead of looming votes [WESA] Property Record Search [Allegheny County] PODCAST: Can Pittsburgh Afford the NFL Draft? [City Cast Pittsburgh] PODCAST: Are Pittsburgh Schools Closing Or Not?! [City Cast Pittsburgh] Without closures, Pittsburgh Public Schools projects $6M deficit with 4% tax hike [TribLive] Pa. cyber charter reforms give PPS budget unexpected 'wiggle room' amid last-minute revisions [WESA] Pennsylvania restricts weight-loss drugs for Medicaid patients amid budget woes [Spotlight PA] Pittsburgh-area ICE arrests through mid-October more than triple last year's level [Public Source] PODCAST: What Actually Happens During an ICE Raid? [City Cast Pittsburgh] PODCAST: Lo que realmente ocurre durante una redada de ICE [City Cast Pittsburgh] HHS changed the name of transgender health leader on her official portrait [NPR] Former Gov. Wolf, Pa. Democrats slam deadname of Rachel Levine portrait [Go Erie] The Terrible Towel Turns 50 [Pittsburgh Magazine] Pittsburgh lands direct flights to Dublin [Axios Pittsburgh] Learn more about the sponsors of this December 12th episode: Fulton Commons Babbel - Get up to 55% off at Babbel.com/CITYCAST Aura Frames - Get $35 off the Carver Mat frame with Promo Code CITYCAST Become a member of City Cast Pittsburgh at membership.citycast.fm. Want more Pittsburgh news? Sign up for our daily morning Hey Pittsburgh newsletter. We're also on Instagram @CityCastPgh! Interested in advertising with City Cast? Find more info here.
In this eye-opening episode of The Tudor Dixon Podcast, Tudor sits down with author Aimee Donnellan for a deep dive into the meteoric rise of Ozempic—the diabetes drug turned cultural phenomenon for weight loss. Together, they unpack the surprising science behind GLP-1 medications, the growing trend of microdosing, and the real risks users often overlook. Donnellan and Dixon explore how body image pressures, diet culture, and the powerful food industry fuel America’s obesity crisis. They also discuss why the drug has become both celebrated and controversial, and what its popularity means for the future of weight management.See omnystudio.com/listener for privacy information.
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Mood, Behavior, and Quality of Life in Parkinson Disease," Sneha Mantri, MD, MS, Chief Medical Officer at the Parkinson's Foundation, discusses how mood and behavioral symptoms shape the lived experience of people with Parkinson disease across the disease course. Mantri, a practicing movement disorders specialist with extensive training and experience, explains why depression and anxiety often precede motor symptoms, how these issues evolve with cognitive change, and why they remain key drivers of quality of life. Mantri reviews commonly used screening tools – including the PHQ-2/9, Geriatric Depression Scale, GAD-7, and emerging measures like the HOPE questionnaire – emphasizing their role in opening deeper clinical conversations. She also highlights Parkinson's Foundation initiatives that support both clinicians and patients, from PD Health at Home programming to team-based care models. The conversation concludes with ongoing challenges, including cultural barriers to mental health care, access limitations, and the continued need for true mental health parity in Parkinson disease management. Looking for more Movement disorder discussion? Check out the NeurologyLive® Movement disorder clinical focus page. Episode Breakdown: 1:10 – How mood and behavior symptoms shape Parkinson disease quality of life 5:30 – How conversations about mental health in Parkinson disease have evolved 9:25 – Screening tools and practical assessment strategies for mood and anxiety 13:40 – Neurology News Minute 15:50 – Foundation and community initiatives supporting mood and behavior care 19:50 – Remaining gaps, cultural barriers, and mental health parity challenges The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease Gene Therapy ETX101 Demonstrates Significant Effects on Seizure Reduction, Neurodevelopmental Outcomes in POLARIS Phase 1/2 Program FDA Accepts NDA for Low-Sodium Oxybate TRN-257 in Narcolepsy and Idiopathic Hypersomnia Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
You've seen it all over social media. Everyone's talking about GLP-1's. Maybe you've heard the brand names—Ozempic, Wegovy, Mounjaro—and wondered, "What exactly is this, and why are so many women suddenly using it?" If you're in perimenopause and noticing weight gain despite doing everything "right," battling constant cravings, or feeling like your body is working against you... this episode is for you.Dr. Katashia is back on the podcast to break down exactly what GLP-1's are, how they work, and why they might be a game-changing tool for women navigating the hormonal chaos of midlife. She shares her own experience using them at 48, the side effects you need to know about, and the critical steps to take before you even consider starting. This isn't about taking shortcuts—it's about understanding your options and finally getting the support your body needs during this transition.In this episode we explore:The real purpose of your inner autumn — and how ignoring it creates hormone chaosWhat happens when you stop pushing through PMS and start listening to your bodyHow I cycle sync my entire business with the inner seasonsA behind-the-scenes look at my 2025 autumnTune in next week were we dive into Part 2 of this conversation.Resources:Dr Katashia's Website - drkatashia.comFollow Dr. Katashia on Instagram: @drkatashiaCheck her out on Facebook: Dr. Katashia Wellness CollectiveJoin my Hormone Unfiltered NewsletterAbout KateKate Nguy is the founder of Shee Revival and a Certified Hormone Health Practitioner and Cycle-Syncing Strategist who helps busy women in their 30s and 40s balance their hormones and reclaim their energy. Specializing in the hormonal ups and downs of midlife—from PMS and perimenopause to burnout and cortisol overload—Kate guides women to feel at home in their bodies and live in sync with their natural cycles.. Through cycle syncing, hormone hacks, and nervous system regulation, Kate empowers women to rebalance their hormones, reconnect to their bodies, and revive the vibrant, grounded version of themselves underneath the overwhelm.Tune in now and join the movement toward better hormone health!Follow me @hormoneswithkate on Instagram for more insights, tips, and support!
In this episode of Creating Your Ageless Future, Regan Archibald delivers a powerful deep dive into the science of body composition, metabolic aging, and the peptides reshaping modern regenerative medicine. He breaks down the “Ageless Axis”—the brain, muscle, and heart—and explains how blood sugar, inflammation, mitochondrial function, and visceral fat determine how quickly we age. Regan shares emerging breakthroughs in GLP-1s, Tesamorelin, CJC-1295, AOD9604, and the “Wolverine stack” (BPC-157 + TB500), and reveals how peptides act as metabolic reset systems rather than dependency-forming drugs. Along the way, he celebrates real client transformations, exposes misconceptions about weight loss drugs, explains why muscle is the antidote to gravity, and updates listeners on new Ageless Future pharmacy innovations. This episode is part science class, part biohacking blueprint—everything you need to build a younger, stronger, more resilient future. AGELESS FUTURE:Book Comprehensive Labs: https://agelessfuture.com/longevity-labs/FREE copy of The Peptide Blueprint: https://agelessfuture.com/blueprintSign up for future Health Accelerator Challenges calls LIVE! https://us02web.zoom.us/webinar/register/WN_YZsiUMOzSyqcE8IinC5YEQ#/registrationBooks: https://www.amazon.com/Books-Regan-Archibald/s?rh=n%3A283155%2Cp_27%3ARegan%2BArchibaldArticles: https://medium.com/search?q=Regan+ArchibaldLIKE/FOLLOW/SUBSCRIBE AGELESS FUTURE:YouTube -https://www.youtube.com/@ReganArchibald / https://www.youtube.com/@Ageless.FutureLinkedIn: https://www.linkedin.com/in/regan-archibald-ab70b813Instagram: https://www.instagram.com/ageless.future/Facebook: https://www.facebook.com/AgelessFutureHealth/DISCLAIMER: Here's the info scoop: everything on this channel is purely for educational and informational kicks—definitely not medical advice. We're here to share the good stuff on wellness and longevity, but let's be clear: the FDA hasn't signed off on any of it. Our aim? To inspire and inform, not play doctor. So before diving headfirst into any health crusade, check in with your healthcare pro. Absorb, explore, and stay curious!
Send us a text Support the show Sponsor Affiliates Empowering Your Health https://www.atecam.com/ Get YOUR Own Joburg Protein Snacks Discount Code: Damaris15 Or Damaris18 Feeling need to Lose Weight & Become metabolically Healthy GET METABOLIC COURSE GLP 1 REseT This course is designed for individuals looking to optimize their metabolic health through integrative and functional medicine approaches. Whether you're on a GLP-1 medication or seeking natural ways to enhance your metabolic function, this course provides actionable steps, expert insights, and a personalized roadmap sustainable wellness. Are you feeling stressed, tired, or Metabolism imbalanced? Take advantage of our free mindful steps to help improve your well-being.ENJOY ONE OF our Books Mindful Ways Health Wealth & Life https://stan.store/Mindfullyintegrative Join Yearly membership ALL IN ONE FUNCTION HEALTH Ask Us for help...
澳洲醫藥用品監管局(TGA)近日更新安全資訊,針對常用於糖尿病的 GLP-1 促進劑加入新警示,當局收到部分不良事件通報涉及自殺念頭,有本地醫學教授呼籲藥物使用者勿「自行停藥」。
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a myriad of transformative advancements and strategic shifts within these industries, illustrating the profound impact of innovation and regulatory changes on healthcare.Eli Lilly's recent strides in obesity treatment highlight a significant scientific breakthrough with their novel drug, retatrutide. Currently in phase 3 trials, this triple agonist targets GLP-1, GIP, and glucagon receptors, achieving an extraordinary 28.7% weight loss in participants. Additionally, it demonstrated a 75.8% reduction in knee osteoarthritis pain. Yet, the journey to this milestone wasn't without challenges. The trials saw a higher discontinuation rate than earlier studies, reminding us of the delicate balance between efficacy and patient tolerability—a consistent theme in obesity pharmacotherapy as developers strive to maximize benefits while minimizing adverse effects.In a testament to the global nature of drug development, Zealand Pharma has embarked on a $2.5 billion collaboration with a burgeoning Chinese biotech firm. This partnership aims to advance oral cardiometabolic therapies, underscoring the crucial role of strategic alliances in accessing innovative scientific platforms and expanding market reach.Rezolute faced a significant setback with a disappointing phase 3 trial for its hypoglycemia treatment, resulting in an 87% drop in stock value. This starkly illustrates biotech's inherent volatility and the critical importance of robust clinical trial design to mitigate financial risks associated with unsuccessful outcomes.Meanwhile, Moderna is leveraging Nanexa's expertise in long-acting formulations to enhance injectable therapy delivery systems. This collaboration is indicative of a broader industry trend focused on optimizing drug delivery technologies to boost efficacy and patient compliance.Operational restructuring is also evident as Pfizer implements cost-cutting measures, including layoffs in Switzerland, as part of broader strategic initiatives to optimize operations amid rising R&D costs and pricing pressures. Simultaneously, Chris Boulton's transition from Amgen to Prolynx underscores the fluid movement of talent within the industry—a reflection of ongoing strategic realignments.Regulatory landscapes are shifting as well. The FDA's approval of the first non-drug at-home treatment for depression marks an expansion into alternative therapeutic modalities beyond traditional pharmaceuticals. This wearable device offers adults with major depressive disorder a novel treatment option, integrating technology into mental health care—a promising addition to holistic treatment strategies.In another significant regulatory update, Teva Pharmaceuticals agreed to delist numerous patents from the FDA's Orange Book following an FTC ruling. This move is anticipated to foster increased generic competition and potentially lower medication costs for conditions like asthma and diabetes—a critical shift towards greater market accessibility.The FDA has also finalized guidance on promotional materials for biologics and biosimilars, standardizing advertising practices to ensure accurate representation of these products' efficacy and safety profiles amidst an expanding biologics market.Moreover, the FDA has launched its Commissioner's National Priority Voucher Pilot Review Program to expedite critical drug approvals. The first beneficiary under this program was USAntibiotics with Augmentin XR, signaling a potential shift towards more rapid access to essential medications.On the international policy front, recent developments between the UK and US have led to reductions in medicine rebate rates within the UK. This adjustment could lead to increased spending on new medicines, indicating more favorable conditions for pharmaceutical Support the show
https://apps.apple.com/us/app/menu-order-ai-find-glp1-meals/id6753690910Learn practical strategies for dining out confidently while taking GLP-1 medications. Find out which meals minimize side effects, how restaurants are adapting their menus, and the essential tips for any restaurant or delivery app without the guesswork. Orderappai City: Boston Address: Congress Street Website: https://www.orderappai.com/
In this powerful client spotlight, Daria opens up about her long-game transformation. Navigating a lipedema diagnosis, multiple surgeries, and the mental load that comes with it—while committing to a simple promise: never live above 200 pounds again. We dig into the routines and mindsets that actually stick: consistent training, protein-forward meals, community support, and self-advocacy in a confusing healthcare landscape. Daria also shares her GLP-1 experience for managing food noise, the role of coaching accountability, and how letting go of rigid expectations unlocked real momentum. If you need proof that showing up beats perfection, this is it. APPLY FOR COACHING: https://www.lvltncoaching.com/1-1-coaching SDE Method app: https://www.lvltncoaching.com/sde-method-app The Fitness League Waiting List https://u3rwk.share.hsforms.com/2rkAwsFntTAeZ__PxwXdr4Q Macros Guide https://www.lvltncoaching.com/free-resources/calculate-your-macros Join the Facebook Community: https://www.facebook.com/groups/lvltncoaching FREE TOOLS to start your health and fitness journey: https://www.lvltncoaching.com/resources/freebies Alessandra's Instagram: http://instagram.com/alessandrascutnik Joelle's Instagram: https://www.instagram.com/joellesamantha?igsh=ZnVhZjFjczN0OTdn Josh's Instagram: http://instagram.com/joshscutnik Chapters: 00:00 Introduction to Daria's Journey 02:25 The Long Game: Commitment to Health 07:21 Understanding Lipedema: A Personal Diagnosis 13:26 Choosing to Keep Moving: Overcoming Challenges 16:39 The Role of GLP-1 Medications in Weight Management 20:07 Navigating Dietary Choices with Accountability 22:09 Consistency in Lifestyle Changes 25:05 Establishing a Routine for Success 29:21 The Power of Simplicity in Nutrition 30:42 Embracing Change and Overcoming Challenges 33:38 Letting Go of Past Expectations 36:41 Gratitude and Reflection on the Journey
When rapid weight‑loss drugs hit mainstream trends, we knew we couldn't stay silent. So we invited our friends and medical pros from SPMJ Aesthetics – Dr. Mary Jordan (board‑certified surgeon & obesity medicine advocate) and Shaun Paulson NP (nurse practitioner, metabolic wellness specialist) – into the studio for a no‑BS, live panel discussion. Together we break down what's real (and what's not) about GLP‑1 medications, body composition, muscle preservation, nutrition and long‑term health. This isn't a "quick fix" talk. It's about doing transformation with integrity, science, and strength. Dr. Mary Jordan is a board‑certified surgeon and co‑founder of SPMJ Aesthetics, with decades of experience, now focusing on medically supervised weight‑management and metabolic wellness through SPMJ Aesthetics. Shaun Paulson NP is a nurse‑practitioner and skin rejuvenation expert, specializing in healthy aging from the outside in. Connect with SPMJ Aesthetics: Website IG Here's what this GLP‑1 conversation will help you understand: GLP‑1 meds aren't magic unless you build the foundation. Fat loss without muscle‑sparing practices can lead to strength loss – but with protein, resistance training, and smart nutrition, you can lose fat and preserve or build lean mass. Sustainable progress > "fast and gone." Aiming for roughly 1 pound per week and backing that with strength work and adequate fuel helps preserve metabolism, energy, and long‑term health. Health is deeper than the scale. When fat loss is done right (with nutrition, exercise, and medical supervision) you lower inflammation, support metabolic balance, protect connective tissue/skin, and avoid the "gaunt" side‑effects we see online.
Get my newest workshop replay, BRILLIANT - Understanding the Somatic Intelligence of Over- & Underfunctioning.Lindsey pulls back the curtain on two sets of her bloodwork (June 2024 → December 2025) to show how healing the nervous system — and lowering the total life load — changes measurable physiology. She explains why over-functioning isn't a personality trait; it's a survival physiology that drives inflammation, insulin, thyroid conservation, liver burden, and stress-lipid patterns. She walks through each lab marker in plain language, contrasts meds/supplements alone with nervous-system and lifestyle change, and shares the supportive protocol she used alongside big shifts in emotional, domestic, and relational load. She closes with how the BRILLIANT workshop and CRUCIBLE practice space fit into this work.Show notesBig ideasOver-functioning is physiology, not personality; your body keeps the score.You can't out-supplement or medicate chronic over-functioning; support helps, and change lands when load drops and safety increases.Low-threat, well-nourished, well-rested physiology shows up clearly in labs: inflammation, insulin, thyroid conversion, lipids, and liver enzymes all move toward safety.Lab highlights (June 2024 → December 2025)CRP (inflammation): 3.0 → 0.9 (≈ 66% drop; low-inflammation range)Fasting insulin: 17.7 (insulin-resistant) → 6 (insulin-sensitive)Thyroid: TSH 3.22 → 1.23; Free T4 0.81 → 1.15; Free T3 2.88 → 3.2 (robust conversion)Liver enzyme (ALT): 33 → 15 (burden eased)Triglycerides: 105 → 68LDL-C: 126 → 97DHEA: 58 → 48 (healthy downshift within the improved overall pattern)What changed besides the numbersLoad reduction: less emotional labor, less domestic/relational over-functioning, fewer sensory demands, more boundaries.Inputs: consistent eating (enough), deeper sleep, real rest, improved circulation/movement without overdrive.Result: cortisol normalized — inflammation down, insulin normalized, thyroid conversion improved, liver less burdened, hair loss reversed, energy steadier.Supportive protocol (alongside the lifestyle shift)NP Thyroid (desiccated), bioidentical progesterone (vaginal delivery), low-dose naltrexone 4.5 mg.Magnesium (glycinate + l-threonate), glycine (~ 3 g/day), vitamin D3 + K2.GLP-1 experience: brief full-dose trial (too suppressive) → discontinued; later micro-dosed retatrutide after nutrition and rest were restored.Who this episode helpsOver-functioners who “look fine” but see inflammation, insulin resistance, sluggish thyroid conversion, stressed liver enzymes, or stress-lipids.Under-functioner/over-functioner couples wanting physiology-and-practice-based next steps.Mentioned resources & linksPrevious episode for backstory — Episode 131: Listen on SpotifyLindsey's ebooks: When Rest Feels WrongWhen Action Feels WrongSupplements Lindsey uses/loves: Glycine supplementHemaplexD3 + K2Magnesium glycinateMagnesium l-threonateFree Video Series:Unfiltered Real Talk About OverfunctioningThe Underfunctioner's Wake-Up CallNotes & gentle disclaimerThis episode shares one person's labs, context, and protocol decisions. Work with a trusted clinician for your own evaluation and dosing — and use these insights to track the impact of real rest, nourishment, and load reduction over time.
It's estimated that as many as 10 per cent of adults in Canada use a GLP-1 type drug like Ozempic. The prescription medicine is used for type 2 diabetes management and increasingly prescribed off-label for weight loss. And this month, for the first time, the World Health Organization has conditionally recommended GLP-1 drugs for the long-term treatment of obesity.But while these drugs have been called a game-changing tool to manage a complex and stigmatized health condition, there's also a lot of questions about the potential negative impact.With Ozempic's patent set to expire soon in Canada, and more affordable generic options about to hit the market, a lot more people you know could end up on a weight-loss drug.Today we bring you the rise and risks of GLP-1s with help from Dylan Scott. He is a Senior Correspondent at Vox who covers health.For transcripts of Front Burner, please visit: https://www.cbc.ca/radio/frontburner/transcripts
Welcome to Real Food Recovery, a podcast created by two lifelong processed food addicts with over 100 years of addiction (and recovery) between them. Paige Alexander and Jamie Morgan Reno use their Real Food Recovery podcast and social media channels to share their struggles, lessons learned, tools, tips, and resources that freed them from decades of food addiction, obsession, and loss. Join us as we welcome Anja Hall, a chef, wellness entrepreneur, and metabolic health advocate who has built four successful companies centered on cooking, high-quality food, and health. She is the co-founder of The Blood Sugar Method, a program designed to help individuals improve their blood sugar and metabolic health through holistic, long-term practices, particularly in cases involving PCOS, menopause, pregnancy, GLP-1 use, and HRT. A longtime chef for the Golden State Warriors, Cleveland Cavaliers, and other professional athletes, Anja knows firsthand how food fuels performance and longevity. She has also competed—and won twice —on the Food Network, proving that nutritious eating can be both gourmet and delicious. You can find Anja at www.thebloodsugarmethod.com. In every Real Food Recovery episode, Paige and Jamie take time to answer viewer questions about processed food addiction, obsession, and recovery. Be sure to submit yours on their YouTube Channel or Facebook Page. You can also follow Real Food Recovery on Instagram (@realfoodrecovery4u), TikTok (@realfoodrecovery) or at www.realfoodrecovery4u.com.
Learn about the FDA's new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers.GLP-1 Pipeline Update: November 202500:00 Overview00:49 Introduction to oral GLP-1s02:43 Evidence from clinical trials10:28 Big picture if FDA approves oral GLP-1s14:08 Must know: Non-peptide vs peptide15:45 More patient friendly formulation?17:38 Market & timing for oral GLP-s Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.
(00:00 - 7:10) Today's DM Disaster is from Christine! She kept her New Year's resolution and lost over 50 pounds without using and GLP-1's. Now her friends think she has a toxic attitude all thanks to her weight loss. That's Christine's DM Disaster! (7:10 - 16:13) 90's folks rejoice! The 90's Christmas is making a comeback; we're talking about tinsel, bubble lights! LBF is all for this; Bob does have a cautionary tale about Cats and tinsel. (16:13 - 20:14) Today's Supah Smaht Player is Stephanie from Windam, N.H. Were they Supah Smaht! (20:14 - 23:46) Tis the Flu season. We talk about when you get sick who gave it to you! LBF says it's the season to stay away from kids! When Bob gets sick, he always wants to find out who did it. (23:46 - 34:48) LBF still has blank Christmas cards from last year, so instead of buying new ones and taking a new photo, she's just going to use the leftovers from last year. Bob talks about his worst interview ever! All this and more on the ROR Morning Show with Bob Bronson and LBF Podcast. Find more great podcasts at bPodStudios.com…The Place To Be For Podcast Discovery! Follow us on our socialsInstagram - @bobandlbfFacebook - The ROR Morning ShowSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Send us a textSchedule an Rx AssessmentWhat happens when GLP-1 compounding, TrumpRx, and PBM audits all collide in your pharmacy?In this episode of the Bottom Line Pharmacy Podcast, hosts Austin Murray and Bonnie Bond, CPA, are joined by healthcare attorney Dae Lee of Buchanan Ingersoll to unpack the fast-moving legal and regulatory landscape around GLP-1s, PBMs, and audits—and what independent owners need to be doing right now to protect their businesses.We cover: - The vertical integration behind the “big three” PBMs and their rebate aggregators- Why PBM audit triggers and the realities of today's audit tactics- A practical roadmap for responding to an audit- What “recredentialing season” really means- TrumpRx And more!More About Our Guest:Dae Y. Lee, Pharm.D., Esq., CPBS focuses on representing pharmacies in their dealings against Pharmacy Benefit Managers (PBMs). With extensive experience in the intricacies of PBM audits, investigations, network enrollment, network suspension, network terminations, reimbursement disputes, and DEA as well as other governmental investigations, Dae has become a trusted advisor to a broad cross-section of pharmacies and pharmacy providers, including community retail pharmacies, chain pharmacies, compounding pharmacies, specialty pharmacies, mail order pharmacies, home infusion providers, and dispensing physician practices.. His practice also extends to assisting other stakeholders in the pharmacy industry such as wholesalers, manufacturers, and other healthcare providers. In addition to his PBM-focused work, Dae represents entities in pharmacy-related transactions and assists clients with corporate formation, due diligence, licensing, change-of-ownership requirements and credentialing, providing comprehensive legal support throughout the transaction process. Dae is a Certified Pharmacy Benefits Specialist™ (CPBS™). Offered through TransparentRx and accredited by the University of Kentucky School of Pharmacy, the CPBS program is designed to cover complex topics of pharmacy benefit management in order to provide a foundational knowledge required for higher-level evaluation of PBM business operations, fundamentals of PBM pricing, plan design, cost-containment strategies, PBM contracts, PBM procurement, Specialty Pharmacy benefits management, and overall PBM performance with emphasis on cost effectiveness.Stay connected with Dae and Buchanan, Ingersoll, & Rand: Dae Lee LinkedInBuchanan, Ingersoll, & Rand WebsiteBuchanan, Ingersoll, & Rand LinkedInBuchanan, Ingersoll, & Rand TwitterBuchanan, Ingersoll, & Rand FacebookStay connected with us on social media:FacebookTwitterLinkedInMore on this topic:Podcast: The Startup Compounding Pharmacy PlaybookPodcast: The Trusted Pharmacist: Advocacy and Building a Resilient PharmacyPodcast: From Counter to Capitol
There's milk everywhere: more milk in the U.S., Europe and New Zealand than a year ago, soft Class IV, and Class III futures that could slip into the $13s once you plug in today's spot cheese and whey. With a long milk wave crashing over the dairy industry, will farmers start culling cows and leaving stalls empty? Inside the episode, the team churns through: Why strong balance sheets, paid-down debt and high cow values could delay a production pullback How lower feed costs shift the breakeven – but can't fully offset falling milk checks Why Western and cheese-focused regions like the Pacific Northwest, California and Idaho may struggle first How WPC 80, WPI and clear whey proteins have become the lone bulls – and why capacity constraints limit the industry's response Why there are limits to what customers can pay for whey, and where substitution is already happening It's a barn full of bears on butter, cheese and fluid milk, but the protein complex is still flexing. The question is how long that can last? Tune in to The Milk Check episode 88: One bull in a barn full of bears to hear how our traders are navigating a market that's bearish on volume but still bullish on protein. Got questions? We'd love to hear them. Submit below, and we might answer it on the show. Ask The Milk Check Ted Jacoby III: Welcome, everybody, to The Milk Check. It is December 5th. We’re gonna talk about markets today. And rather than boring you and having the same conversation we had three weeks ago, everything is still bearish. There’s milk everywhere. There’s milk all over the U.S. There’s milk all over Europe. There’s milk all over New Zealand. There’s a whole bunch more milk this year than last year. Things are long. It’s very likely things are gonna get longer before they get shorter. Today we have some of our usual suspects. My brother Gus has joined us today. We’ve got Josh White, we’ve got Joe Maixner, we’ve got Diego Carvallo. And, of course, myself. Looking forward to a great conversation. So, rather than discussing how bearish we can be on these markets, my question, and I’m gonna start by throwing this question at my brother, Gus, is Gus, how long do you think it’s gonna take for dairy farmers to start culling cows and for this milk [00:01:00] production to slow down? Gus Jacoby: I feel like milk price and farm economics are completely contingent on that and how bad those farm economics get with respect to the milk price. Class III is still relatively high. Obviously, Class IV is pretty poor right now. The way I see it, dairymen, at this moment in time, still have fairly strong balance sheets. So, the recent low prices haven’t affected ’em all that much. So, I don’t expect their behavior with respect to culling and whatnot to change. But I think in five, six months from now, assuming that the milk price is at or lower, and quite frankly, I think Class III probably does need to get a bit lower, you’ll start to see some of that behavior change. If I had to guess, either as early as early summer, but as late as maybe mid-fall, if farm economics don’t change, we’ll start to see dairymen begin to leave stalls open. I mean, they’re gonna cull a cow, collect that beef revenue that they can grab, and not necessarily buy the expensive heifer. Ted Jacoby III: You’re thinking it’s gonna take about six months for dairy farmers [00:02:00] to get to the point where they feel like they need to increase the amount of cows they’re selling in order to meet their cashflow needs? Gus Jacoby: That’s my best guess. And again, that can be either expedited or slowed down depending on where the milk price goes. Ted Jacoby III: Corn prices have really come down this year. Do you think the lower feed prices have lowered where that break even point is, or how low we need to go in milk price in order to really send those signals in a strong way? Gus Jacoby: Certainly, feed prices being lower are gonna be helpful to the farm economic model. This becomes a milk price discussion. If the cheese price continues to have that downward pressure and gets low enough, those feed prices won’t be low enough. It’s always related to their inputs. And certainly, cheap feed helps their cause to extend growth in the milk production model. Ted Jacoby III: Right now, on December 5th, the Class III prices for the first quarter are right around, let’s call it $15.50, but if you use today’s cheese price on the spot market at the CME in today’s whey price, you’re probably looking at something closer to $14, 14 and a quarter. [00:03:00] Is that low enough or do we need to go lower? Gus Jacoby: It’s low enough. But not low to expedite anything. Maybe that takes us into the late summer, and remember, it depends on where we’re talking here in the country. Milk production costs are different depending on where you exist in the country. And also payouts are a lot different in a lot of places, depending on where you exist in the country. So, some regions might struggle sooner than later. Ted Jacoby III: Which regions do you think are gonna struggle first? Gus Jacoby: The West, Pacific Northwest, I think California, areas like Idaho that are strongly cheese based. If you’re paying on a Class III price and it stabilizes, which I don’t anticipate here, then perhaps some of those regions might hold on longer. My guess is predicated on the forecast of Class III going a bit lower. Ted Jacoby III: I guess I’d have to agree with that ’cause I don’t think $14 a hundredweight is enough. Because we’re still in front of Christmas, and I think the market’s probably gonna get worse before it gets better. My hunch is we’re gonna see $13 milk this year. We’re gonna see it in Class IV, and we may be already [00:04:00] seeing it in Class IV as soon as December. I think we’re gonna see a 13 handle in Class III, probably most of the first quarter. Gus Jacoby: If you’ve got a Class III at 13, and Class IV holds as low as it is, which I would expect certainly in the first half of the year, and then you have your standard freight and other deducts in those milk checks, dairymen are now getting to an area that is very adverse. Ted Jacoby III: Even though we’re talking about really low prices, I think there’s a lot of dairy farmers out there that are in a pretty healthy place. Gus Jacoby: I would agree. Ted Jacoby III: They’re healthy in two ways. One, I think that many of them have been able to take the last two years and really pay down their debt. And so, they’re in a really good spot financially, just on the balance sheet alone. But the second thing is those cows, they’re worth twice what they were worth three years ago. And so, not only have they paid down their debt, but if they need to borrow more, they’ve got more collateral to borrow against because those cows are usually the collateral for the banks when the banks lend dairy farmers money. It’s [00:05:00] usually the cows and the land. My hunch is that this may go on longer than we expect because of how healthy dairy farmers are financially today. Not saying they’ll be healthy in four or five months, but they’re healthy today. And because of how much bankers are probably willing to lend them based on those balance sheets. Gus Jacoby: I agree that the balance sheets are strong at the moment, even after a couple tough months. But I would also add, that that can change fairly quickly if the milk price gets low enough. And it’s certainly a ratio of farm economics over a certain period of time and milk price. If it gets low enough and makes those farm economics adverse enough, it can expedite the issue, which is a plausible scenario right now. Ted Jacoby III: Mm-hmm. I would agree with that. I think the hardest thing, especially when you have a falling market like we do right now, is to try and figure out exactly where the bottom is. About a month ago, the bottom was about a $1.40. Well, guess what? Cheese price is already below a $1.40 Now, we’re hearing it’s gonna be [00:06:00] somewhere in the $1.20s. What I’m scared is we’re gonna get to the $1.20s, and somebody’s gonna start talking about maybe we need to go into the teens. I don’t know if we’re gonna go that low, but we’re definitely in that scenario right now, where you have a market that’s falling and nobody has a really good feel for where that bottom is. Gus Jacoby: I agree. Cheese and butter right now, their outlook over the next six to eight months does not look good. Ted Jacoby III: Yeah. You mentioned butter. Joe, I’ll ask you: we’re below a $1.50 in butter. Butter feels like maybe it’s caught a temporary floor. Is this a temporary floor or could we stabilize here for the next six months? Joe Maixner: I think we’ve hit a temporary floor, but I don’t think it’s the lowest we’ll see over the next 90 days. I think that cream seems to be in balance, even after Thanksgiving, and I think it’s kept a nice spot in the market where people are willing to buy, those that hadn’t already put contracts on for next year are seeing the 2026 numbers and they’re looking at that against their budgets and blocking volume up for next year. A [00:07:00] lot of first half volume’s already been booked. We’re just seeing more activity. We’ve hit that level of support. Ted Jacoby III: Joe, you mentioned cream. Gus, I’m gonna go back to you. We had some really ugly cream multiples the first half of last year. Have we increased churn capacity, and do we expect those multiples to be just as bad this year or have we increased churn capacity enough so that maybe they won’t quite get so bad? Gus Jacoby: We have increased churn capacity, certainly. I don’t know if it’s enough. Some dairymen around the country are feeding their rations a bit different and getting a little bit less butterfat out of the milk. I don’t think that’s enough, yet, to make too much change. I will anticipate having some very low multiples through the holidays and the spring flush. Ted Jacoby III: Okay. Diego, I’m gonna switch gears and come to you. We just talked about U.S. milk production. Gus thinks it’ll take about six months to turn. I hate to be really pessimistic, but my gut, and I just can’t shake this gut, is it’s gonna take longer than usual this time around. And we may see it go well past nine months before we see a real turn. [00:08:00] We may see the number get better simply because we’re measuring against strength, but that doesn’t mean we actually see a change in trend. What about Europe and some of the other milking regions in the world, is it gonna take that long us to see some changes in milk production in those regions? Diego Carvallo: If you just go to the fundamentals and you analyze that the European farmer usually has a smaller scale, and that means that their costs tend to be a little bit on the higher end. They do not have access to capital as there is in the U.S. There’s more restrictions when it comes to environmental, and overall I would say they have more headwinds than the U.S. So, if you add to all of those headwinds, the price headwind, the reaction on milk production to lower prices should be faster than in the U.S. The same applies to South America. But we’ve talked a lot about Chinese production, we know that in that country, there are way more things to take into account. Ted Jacoby III: [00:09:00] So, we’ve been talking a lot about the supply side today. We’re just overwhelming supply on the butter side; we’re overwhelming demand to a lesser extent, but still on the cheese side. Josh, protein still tends to be the shining star. But are we getting to a point where we’re starting to get some pushback on protein prices? And is that going to continue to be the lone bull in an overall bearish dairy market, or do we need to be concerned there too? Josh White: I don’t think we’re getting pushback at the prices quite yet. Does that mean I think that these prices are palatable over the long term? I’m unsure. But what we are seeing right now is lack of availability and no quick ability by the European market or the U.S. market to scale production to meet the demand, which means that ultimately, the demand for WPC 80 and WPI and then some of the more value-added proteins, particularly in the whey complex, like the clear WPIs, the acidified products and others, the demand is outpacing our ability to supply it. What that’s [00:10:00] doing is forcing utilization segments or customers that can’t compete in terms of price for that available supply to look to alternatives. We’re starting to see more and more of that. As a commodity trader, we expect that to happen quicker than it does. So, already in early 2025, we were looking towards MPCs, casein-related products and others to pick up some of that demand because they’re much lower value. And I don’t think that the average customer in the market that’s using whey proteins fully recognize the functional differences between whey proteins and milk proteins. And they certainly don’t realize that milk protein concentrate has whey protein in it. Generally speaking, the average consumer doesn’t know the difference in these products. That’s not a fault of theirs. Particularly going into CPG applications and further processing, this is an ingredient. An ingredient that has a lot of label recognition and popularity right now for all the reasons we’ve talked about in prior podcasts: GLP-1 driven demand, [00:11:00] health and wellness movements globally, a lot of other reasons. Is that an early indication that enough time has now passed that the relative value of whey protein above the competing, but still quite valuable proteins in the dairy complex, are gonna result in substitution both substitution within the dairy category to whey protein to milk protein concentrates to micellar casein to WPC 70, also known as WPPC, whey protein phospholipid concentrate (WPPC) ProCream. There’s a lot of different names for these products. That’s likely to happen. But it also, unfortunately, might result in a lot of categories pushing to non-dairy proteins. There’s a lot of information out there, things put on by ADPI and others talking about the protein power of dairy and how digestible it is. How high quality it is for your conversion rate, why it’s such a popular thing. But if you can’t get supply, you’re forced to look to alternatives. And so, we’re starting to see some of that [00:12:00] happen. So, a couple things that I’ve heard anecdotally in the market over the past few weeks in particular, but it’s been happening over the last few months are: get us samples of milk protein concentrate. One of our customers is suspending a certain SKU on the shelf because they can’t get the supply. This price simply won’t work for our application. So, we won’t buy this product at above this price. So, we are triggering some thresholds. And triggering thresholds is gonna have some type of balancing result in the industry. Whether that’s enough to support the milk protein side of the equation, I don’t know. We have a limit to the ability to respond to this demand. You have to order equipment, you have to get the bank lending, you’ve gotta get the design. It takes a long time to increase capacity. That’s all gonna come into play and impact this market and the balance of this market in 2026. Now, if you’re asking me, is my gut that we hold these high prices or even higher prices without some reversal in the price [00:13:00] action for whey proteins in 2026? I’m not ready to say that it’s just here or higher in 26, but is it here or higher in the first quarter? Absolutely. Is it here higher in the second quarter, probably. Is it here or higher after that? I become a little bit skeptical. And to be clear, that’s not because the demand isn’t there right now. The demand feels like it’s there. I just don’t know how the market balances it out without pushing the price just too high in the short term for the market to digest it and pass it through. I also think that when you’re talking about the dairymen and you’re talking about the cheese makers, there is two different classes here. There is the class of those that make whey proteins and the class of those that do not. That has a material impact on profitability throughout the supply chain. Additionally, we’ve got a lot of milk in the U.S. We’ve got a lot of milk in the world right now, and the milk in the Northern hemisphere altogether is only gonna increase from here through the first half of [00:14:00] the year. That milk is gonna need to be processed. The incremental milk production will result in incremental whey protein availability, which means that those whey solids from cheese processors they have to find a market. If you can’t make the valuable product of WPC 80 and WPI, you have to explore the other alternatives, which are simply not experiencing the robust demand of those two categories. Sweet whey powder, whey protein concentrate 34% (WPC 34) and some of these other products, they have a limit to what people are willing to pay. History tells us, at least for sweet whey powder, we’re testing those limits. Ted Jacoby III: For sweet whey powder, we are, the question is, is this happening for whey protein? And that’s a harder one to answer. Josh White: Absolutely. Ted Jacoby III: I did some back of the envelope math. As a country, we produce 8% to 9% more milk in May on a daily basis than we do in November. If half of that milk goes into cheese, we’ll produce 8% more cheese and 8% perhaps more whey protein. The solids change, too. So, maybe it’s not a full [00:15:00] 8%, but is 8% enough to tip the scale on whey protein demand? And I don’t know, given the demand complex for whey, I think for cheese it’s gonna feel very burdensome. I think for butter, it would probably feel pretty burdensome. The butter market we’re kind of used to it because of the way the demand curve looks, but I just don’t know when it comes to whey, if that’s enough to put some pressure on this market and bring those prices down. Josh White: Well, it depends on what you’re talking about because you could argue that the WPC and WPI facilities are bringing in outside whey solids. Mm-hmm. Mm-hmm. As their own milk and their own whey generation increases seasonally, that’s gonna push whey solids back to somebody else. So, all 8% in your hypothesis there, I doubt contributes to an 8% increase in whey protein production. Because the available capacity isn’t there? Josh White: Correct. Now, is there production efficiencies that are still gonna be gained? Are there those out there that are expanding a bit [00:16:00] that we’re unaware of? Are there orders for new equipment in the system that might be closer to realization than we think? All possible. And we can’t ignore Europe. I don’t feel like I can adequately represent what the expansion model looks like in Europe right now for whey proteins. What I can say is that at least for the U.S. and Europe, our internal demand is currently absorbing a greater percentage of our production than ever before, and that’s leaving the rest of the world that was buying product from those two markets, having to search for that protein elsewhere. Ted Jacoby III: Mm-hmm. Josh White: And, this is being a bit over generic, but the rest of the world likely will be more willing to substitute than the U.S. or the European consumer to other products. Ted Jacoby III: I would agree with that. Everybody in our office is just leaning really bearish, just about everybody we talk to seems to be leaning really bearish. Josh White: Outside of Black Swan events: major trade disruptions, major production impacts that we can’t predict. If you’ve [00:17:00] been in the dairy industry long enough, you know to never bet against the dairymen and their ability to make milk. But it’s gotta be on the radar that the competitive dollars for those animals I don’t think has ever been as lucrative as it is right now. And those animals that they’re currently milking are older then typically they want them to be. So, if we shift this cycle quickly enough and violently enough, and that’s price, at what moment do we get surprised at what that residual response is? How many pent up animals find their way to slaughter? How quickly that could happen. And I think generally speaking, most of us would bet that the calf inside the dairy cow right now is worth enough to wait. And so, we’ve gotta get through the first half of the Northern Hemisphere season before we see much of an animal response. Ted Jacoby III: I think that’s a fair comment. Dairy farmers, especially the big financially astute ones, there’s a math equation. It’s like, this is my revenue [00:18:00] from milk. This is my maybe revenue from biofuels or wherever else. They have revenue streams from a cow that’s giving milk every day. This is the cost to maintain that cow. The variable cost feed, for example, being the big one. Well, when you’re getting $20, a hundredweight from your milk versus $13, a hundredweight for your milk. That equation has changed quite a bit, whereas the exit price, what you’re gonna get if you sell the cow hasn’t changed at all, which means your math equation, the exit possibility has definitely gone up. It’s more profitable to sell this cow than it used to be. Josh White: History tells us that the exits of the older dairymen and the smaller dairies doesn’t really change based on economic conditions, it’s relatively stable. Maybe there’s some risk that we have some pent up exits and some risk that it’s never been a better time to retire. Mm-hmm. And you get some smaller dairies that decide to exit. That doesn’t move the needle. Ted Jacoby III: I would suspect. You’re right. We’ll see. Josh White: One [00:19:00] quick remark that’s important is the outlook on demand. It seems like the market is very, very bearish because supply is outpacing demand globally and it’s in every major milk shed. But demand by import regions has been pretty good. Mm-hmm. They’ve been buying year over year, more dairy products. At the same time, I don’t believe there’s any region in the world that’s currently sitting on cumbersome overall dairy stocks, whether that’s from the import regions or the production regions. Everyone seems to be quite aware that you gotta stay in front of this. I don’t know how to interpret that. On one hand, you could say that based on some of the economic outlooks, globally, we shouldn’t be expecting things to get better. We should be expecting them to get at best the same or possibly even worse. On the other side of that equation is import dairy consumption and demand is growing and continues to grow, so it might be a painful period, but the long-term [00:20:00] outlook remains pretty good, and we just overreacted to some of the demand signals that we have. Credit to the dairymen in the world, being able to respond to signals that we needed more fat, not even a year ago. That whey protein demand’s good. I mean, the market has responded, but overall we’re not talking about an oversupply situation because demand’s bad. If you go granularly, like U.S. cheese consumption, doesn’t look real great right now. The outlook for overall economic health, I’m not an expert in that area, but I’m not seeing a lot of people talking about a rosy 12 to 24 months there. So, yeah, I think generally speaking, it’s easy to be bearish, but maybe that’s one thing to pay attention. Ted Jacoby III: You mentioned demand. I happened to be involved in a conversation yesterday with an equities trader and his comment about stock valuations, equities, valuations, which was really a demand comment, was, I’m just waiting to see what Christmas sales do. I think there’s a lot of people out there right now that are trying to get a feel for what’s [00:21:00] the long-term demand or the 2026 demand perspective, and I think a lot of them are gonna judge what it really is based on how this holiday season plays out. All right guys. Hey, thanks for a great conversation. I apologize to all the dairy farmers out there that I couldn’t give you any better news, but hang in there that good news will come eventually. That’s right.
Mind Pump Fit Tip: Hacks to increase daily activity for fat loss and health. (2:55) Training and fueling your teenage kids, and labor-driven school projects. (20:16) The birth of AI consciousness. (26:01) Mind Pump Recommends the Age of Disclosure on Prime Video. (32:28) Thanksgiving festivities. (43:36) Adam updates on the audience on how he is recovering from his Kratom withdrawal. (47:29) How dumb bureaucracy is. (1:02:06) #ListenerCoaching call #1 – Could you use any MAPS programs while taking a GLP-1 medication? (1:05:12) #ListenerCoaching call #2 – The best MAPS program for a stay-at-home mom who is not getting great sleep. (1:14:19) #ListenerCoaching call #3 – How realistic is it to achieve that level of muscle development from a home gym setup? (1:21:51) #ListenerCoaching call #4 – A new trainer wanting advice, how to coach reverse dieting to my clients like a pro. (1:29:08) Related Links/Products Mentioned Get Coached by Mind Pump, live! Visit https://www.mplivecaller.com Visit Crisp Power for an exclusive offer for Mind Pump listeners! ** Code MINDPUMP10 for 20% off. Give your snack game a serious upgrade. Crisp Power Protein Pretzels deliver super crunchy and delicious snacks that are up to 28g of protein, low carb, zero sugar, and high in fiber! ** Visit Legion Athletics for the exclusive offer for Mind Pump listeners! ** Code MINDPUMP Buy one, get one 50% off for new customers, and 20% cash back for returning customers! ** MAPS 15 STRONG 50% half from Dec. 7th-13th. Code DECEMBER50 at checkout. Mind Pump Store Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts Walking 8,000 steps just 1-2 days a week linked to significant health benefits Bret Weinstein on the Birth of AI Consciousness | JRE The Age of Disclosure - Prime Video An Alarming Decline in the Nutritional Quality of Foods California declares kratom illegal, raids stores in Sacramento and San Diego Visit Seed for an exclusive offer for Mind Pump listeners! ** Code 20MINDPUMP for 20% off your first month of Seed's DS-01® Daily Synbiotic. ** Mind Pump #2597: Before You Take Ozempic, Wegovy, or Mounjaro Listen to This! Mind Pump #2572: Only 15 Minutes a Day to Build Muscle & Burn Fat Mind Pump #2530: Why All Women Should Take Creatine Ask Mind Pump Trainer Bonus Series Episode 2: Diet & Exercise Strategies That Work AND Clients Love The Complete Reverse Dieting Guide (E-Book) - Biolayne Store Elite Trainer Academy – Podcast Schedule a Reverse Dieting Strategy call with a Mind Pump coach Mind Pump #2690: The NEW DIET Everyone Is Using For Fat Loss Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Bret Weinstein (@bret.weinstein) Instagram Andrew Huberman, Ph.D. (@hubermanlab) Instagram Layne Norton, Ph.D. (@biolayne) Instagram
Dr. Will Bulsiewicz is a physician, bestselling author and one of the most respected voices in microbiome science. He joins the show for a deep dive into the powerful connection between gut health and inflammation. We break down how the gut impacts every system in the body, why chronic low-grade inflammation is so common, and the surprising signs you may have it even if you feel “fine.” Dr. B shares the number one food for lowering inflammation, why you can't have a healthy microbiome and inflammatory conditions at the same time, and how to start transforming your gut barrier in just 3–5 days.We also dive into the downstream effects of living in negativity and reactivity, the health issues tied to the Western diet, and how restrictive eating can backfire on your microbiome. Dr. B offers evidence-based tools to improve gut health, reduce inflammation, and support overall wellbeing — including non-food lifestyle practices, his essential supplement stack, and the truth about glyphosate and antibiotics.We also explore why you feel better abroad, the gut barrier's circadian rhythm, the 7-day outdoor challenge, the 10-minute habit that makes you happier and sleep better and his most unpopular health stance.This is a concise, practical, science-driven guide to what actually works for gut health and inflammation! Follow Dr. B @theguthealthmd and pre-order his newest book: https://a.co/d/j2qOcAA This episode is brought to you by:Go to armra.com/WELL or enter WELL to get 30% off your first subscription order.Head to boncharge.com and your 25% off code will be automatically added to your order.Go to ro.co/BLONDE to see if your insurance covers GLP-1s for free.Get 25% off your first month at Ritual.com/BLONDE. Go to Quince.com/blonde for 365-day returns, plus free shipping on your order.Get 61% off your first order at everdaydose.com/WELL or use code WELL at checkout. This episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
I am honored to have Dr. Tom Dayspring join me again today for another AMA session. He and I have done eight podcasts before, and this is a continuation of our last Ask Me Anything episode. Dr Dayspring is an esteemed expert on internal medicine and clinical lipidology. He is likely one of the most influential worldwide lipid experts, so I am thrilled to have him back with me to dive into various topics related to listener questions, including the impact of hormone replacement therapy on lipid changes, methods of administration, and why bioidentical hormone replacement therapy is preferable for managing both menopausal symptoms and lipid health. We discuss medications, including PCSK9 inhibitors and GLP-1s, as well as intermittent fasting, lipids, and cardiovascular disease risk. We also examine how heart disease develops gradually, over time, the impact of stress and lifestyle, and Dr. Dayspring shares the labs he recommends beyond traditional lipids, ApoB, and LpA. In our discussion, Dr. Dayspring noted that he was not in a position to speak about GLP-1 therapies or microdosing. Since I received many questions from listeners on those topics, I will host a future solo AMA to address some of their concerns. Today's conversation with Dr. Tom Dayspring is truly invaluable, and I trust you will walk away with valuable insights you can share with your healthcare providers. We created a PDF - cynthiathurlow.com/lipids - specifically for listeners that outlines key labs to discuss with your providers and questions to ask them to help you advocate for your own health and your family members' health. IN THIS EPISODE, YOU WILL LEARN: Why being physically fit does not always eliminate the risk of heart problems arising How ApoB and cholesterol contribute to heart disease over decades Why the early testing of risk factors is essential How chronic stress increases the risk of heart disease How high cortisol affects insulin sensitivity and glucose regulation How stress impacts endothelial and nitric oxide function The link between low Omega-3 levels and heart problems How insulin resistance degrades heart health How high homocysteine levels can impair endothelial function and contribute to cardiovascular problems Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow) Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Dr. Thomas Dayspring On X (@DrLipid) On LinkedIn
Episode Overview From tech-driven coaching to GLP-1 medications and the rise of midlife women as the wellness industry's main demographic, we're unpacking what's really on the horizon for 2026. In this episode, Annie and Jen share the biggest upcoming health trends, what excites them, and what has them raising an eyebrow. This episode is especially helpful if you want to be more discerning about what you see in magazines, your social feeds, and on store shelves—and avoid wasting your time, energy, or money on gimmicks. Get ready to hear what's likely coming, who's benefiting, and how you can stay grounded through it all. If you like what you hear in this episode, don't miss your chance to join us when we open enrollment to join Balance365! Add your name to our obligation-free waitlist, and we will waive the $199 registration fee. Click here to learn more. Key Points How GLP-1 medications are shaping the future of weight loss and food environments Why AI might become your new "coach"—and how to spot the difference The pendulum swing from biohacking to practical longevity habits Why emotional regulation is becoming the next big health behavior How midlife women (finally) became the wellness industry's priority
I'm excited to have Povilas Sabaliauskas, the CEO of Pulsetto, joining me for Part 2 of a two-part series. In Part 1, Povilas explained what the vagus nerve is and how it acts as a necessary mental toothbrush for us. In Part 2 today, he discusses the Pulsetto device itself, the different models, and how it helps to boost hormones, reduce stress, and improve sleep. Stay tuned until the end, where he offers a discount code so you can try the Pulsetto out for yourself. How to Maximize the Benefits of the Pulsetto Use it twice daily Use it consistently, as the benefits increase over time Do a session before bed for better sleep Monitor your HRV, stress, and sleep with a wearable device to track your progress Bio: Povilas Sabaliauskas Povilas Sabaliauskas is the co-founder and CEO of Pulsetto, one of the fastest-growing wellness tech companies in the world. A leader in non-invasive neuromodulation, Pulsetto is redefining how we approach stress, sleep, and recovery — through wearable vagus nerve stimulation backed by science and loved by high-performers around the globe. With a background in tech and performance coaching, Povilas has become a passionate advocate for making cutting-edge wellness tools accessible to everyone — not just elite athletes or clinical patients. Under his leadership, Pulsetto has partnered with leading researchers, completed clinical trials, and grown to over 100,000 users across Europe and the U.S. Povilas brings a unique mix of business strategy, biohacking curiosity, and real-world stress recovery insights — making him a fresh voice in the growing world of neuromodulation and mental resilience. In this episode: How 30 days of consistent Pulsetto use can reduce cortisol levels by almost 50% First-time Pulsetto users often report deeper sleep and vivid dreams How athletes use the Pulsetto to reduce pre-event stress and support their recovery Early data suggest that the Pulsetto can reduce inflammation and lower blood pressure The importance of using the Pulsetto daily to achieve noticeable results The benefits of wearable devices for tracking the effects of the Pulsetto How vagal stimulation can help manage insulin spikes Links and Resources: Use Code FIBER to get 10% off GLP-1 Fiber Use code TURMERIC to get 10% off TURMERIC Calocurb Clinical — Appetite & Craving SupportA practitioner-exclusive, plant-based supplement designed to enhance your body's natural fullness signals (GLP-1 and PYY), helping reduce cravings and calorie intake. Available only through clinics such as the Integrative Health and Hormone Clinic.Visit us or order here: https://ihhclinic.com/ Guest Social Media Links: Povilas Sabaliauskas on LinkedIn Pulsetto Device on YouTube YouTube: Immediate Relief from Stress & Burnout with Pulsetto and CEO Povilas Sabaliauskas YouTube: How to Reduce Stress and Calm Your Nervous System in Just 4 Minutes using a New Device Relative Links for This Show: Use the code Dr. Stephanie Gray for 10% off Follow Your Longevity Blueprint On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online Follow Dr. Stephanie Gray On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast
Become a Supporter of The Real Science of Sport by making a small monthly pledge, and you also get access to our world-class community of experts and enthusiasts. Plus you get to explain sports like F1 and Squash to Gareth and Ross!Show notesToday, we focus on three news pieces from last week that reminded us of other stories we covered during 2025. The first two concern weight loss and management in elite sport, beginning with a look at the GLP-1 agonist issue (28:27). This was triggered by reports in the UK advising people that they must continue to exercise, specifically weight train, in order to combat the loss of lean mass that has been observed on the drug, which some have equated with aging a decade. Elite sport, meanwhile, will have to consider whether to ban such drugs as potentially performance-enhancing or harmful.On the subject of harm, we stay on weight issues to discuss RED-s (40:10), in the light of a remarkable and candid announcement by elite cyclist Veronica Ewers that she's taking time away from the sport to address issues that she explains go back over a decade. Her story highlights all the traps - control and thoughtfulness about discipline, obsession over measurement and gadgets, disordered eating, intense training, positive validation in competitive environments, the remarkable ability of the body to tolerate this punishment, but ultimately, the sacrifice of health in a misplaced pursuit of performance. We talk about the lessons we can all learn, thinking back to Pauline Ferrand-Prevot's victory in the TDFF, which was a success story for weight periodization.We also cover precocious talent, after a three-year old Indian prodigy earned a chess ranking (1:00:40). That reminded us of Malcolm Gladwell's "compression of adolescence" concept, and we talk about the inefficiencies sport accepts in its pursuit of the next champion, highlighted numerous times this year, with the realization that the system is broken and won't be fixed unless there is a collective will be fix it.Also in this show, a more light-hearted look at the Football and Rugby World Cup draws (2:54) has us bemoaning the dilution of quality and the dearth of competitive matches early in those tournaments. And we chat about a super-fast Valencia marathon (10:43), that threw up fast winning times and nine national records, leading to a chat about globalization of the sport, the dominance of African runners, the slowest marathon nations (with some reasons), and the density of men's and women's top performers.Plus Gareth remembers that Curacao is both a drink and World Cup finalist, and Ross defends Ghana's football honour!Other linksReview article advising resistance training in people taking GLP-1 agonistsPaper that examines weight loss after 1 year of exercise or GLP-1 drugsMore in-depth look at appetite and exercise behaviours in that studyStudy finding risk for RED-s in 30% of triathletes, including the tools that can be used to identify risk factorsCycling teams paying young riders big salaries Hosted on Acast. See acast.com/privacy for more information.
Exploring the Microbiome and Longevity with Dr. Ross Pelton, Director of Science & Education for Essential Formulas Inc., which specializes in premium probiotic products. He's known as the Natural Pharmacist. He details the pivotal role of the gut in chronic disease, referencing the ancient insights of Hippocrates, and explores the concept of postbiotics. The conversation touches on the influence of gut health on various organ systems, the importance of diversity in the gut microbiome, and how lifestyle choices like diet, exercise, and sleep contribute to healthy aging. They also tackle cutting-edge topics such as the implications of GLP-1 medications, anabolic resistance, and the potential benefits of rapamycin for longevity.
Doctor Mau Informa ®️#drmauinforma
In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl examine a wide range of stories shaping American health. From new research on the lifesaving ... The post MTT #101: From measles outbreaks to GLP-1 hype, the data every patient should know appeared first on Fixing Healthcare.
TODAY ON THE ROBERT SCOTT BELL SHOW: Vaccine Schedule Evaluation, Parents Reject Vitamin K, Florida mRNA Ban, Santoninum, Cassette Tape Revival, Religious Exemption Victory, GLP-1 Cancer Study, MAHA Targets EPA, Ozempic Muscle Loss, Collagen Questions, and MORE! https://robertscottbell.com/acip-to-remove-hep-b-parents-rejecting-vitamin-k-florida-mrna-ban-santoninum-cassette-tape-revival-supreme-court-religious-exemption-victory-glp-1-cancer-study-maha-wants-epa-administrator-fire/ https://boxcast.tv/view/vaccine-schedule-evaluation-parents-reject-vitamin-k-florida-mrna-ban-religious-exemption-victory-maha-vs-epa---the-rsb-show-12-9-25-x6wsypchvtcfaqkttbdy Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.
The Bald and the Beautiful with Trixie Mattel and Katya Zamo
Official Statement from the esteemed Lushious H. Massacr IV, Esq.: In a moment unprecedented in the annals of human cooperation, the international drag community proudly proclaims the dawn of lasting global concord, achieved through the harmonious power of the Astounding Portal of Unity: The Booty Hole. Let this precious orifice inspire nations to transcend petty grievances and embrace collective purpose and tolerance. The world now stands as a unified polity, fortified by a shared commitment to dignity, mutual respect, and the serene magnetism of this starry symbol. Let this historic declaration affirm Lushious' hopeful belief that even the most unexpected sources may guide humanity toward its highest destiny. Your home might be worth more than you think! Find out how much at https://Airbnb.com/HOST Get your gut going this holiday season and support a balanced gut microbiome with Ritual's Synbiotic+. Our listeners get 25% off your first month at https://Ritual.com/BALD Join the millions of Chime customers who are already banking fee free today! It just takes a few minutes to sign up. Head to: https://Chime.com/BALD For your free insurance check to see if your insurance covers GLP-1s—for free, head to: https://Ro.co/BALD For an exclusive $35 off Aura Frame's amazing Carver Mat Frame, use Promo Code BALD at https://on.auraframes.com/BALD Check out Lushious on YouTube: LushiousMassacr Follow Lushious: @LushiousMassacr Follow Trixie: @TrixieMattel Follow Katya: @Katya_Zamo To watch the podcast on YouTube: http://bit.ly/TrixieKatyaYT To check out our official YouTube Clips Channel: https://bit.ly/TrixieAndKatyaClipYT Don't forget to follow the podcast for free wherever you're listening or by using this link: https://bit.ly/thebaldandthebeautifulpodcast If you want to support the show, and get all the episodes ad-free go to: https://thebaldandthebeautiful.supercast.com To check out future Live Podcast Shows, go to: https://trixieandkatya.com/#tour To check out the Trixie Motel in Palm Springs, CA: https://www.trixiemotel.com Listen and Watch Anywhere! http://bit.ly/thebaldandthebeautifulpodcast Follow Trixie: Official Website: https://www.trixiemattel.com TikTok: https://www.tiktok.com/@trixie Facebook: https://www.facebook.com/trixiemattel Instagram: https://www.instagram.com/trixiemattel Twitter (X): https://twitter.com/trixiemattel Follow Katya: Official Website: https://www.welovekatya.com TikTok: https://www.tiktok.com/@katya_zamo Facebook: https://www.facebook.com/welovekatya Instagram: https://www.instagram.com/katya_zamo Twitter (X): https://twitter.com/katya_zamo #TrixieMattel #KatyaZamo #BaldBeautiful Learn more about your ad choices. Visit podcastchoices.com/adchoices
In this special episode, Savannah and Julie discuss everything from the joys and challenges of parenting to the excitement of the upcoming holidays. Julie shares an update on her readjustment since her release, including her new quirky habits she's picked up along the way. We also touch on Chloe's school life and how hilarious she is, plus the importance of family traditions during the holidays.They also explore the concept of "gray divorce" and how societal changes are impacting relationships. They also share some personal stories from a recent trip to Vegas, including a wild ride-share experience that you won't want to miss!Plus, we talk about Savannah's health journey with GoodGirlRX, including GLP-1 and peptide therapy, and how we're planning to tackle the new year with a focus on wellness.Don't forget to like, share, subscribe and leave a review!Thank you to our sponsors for supporting our show!- Quince: Step into the holiday season with layers made to feel good, look polished, and last—with Quince. Go to https://www.Quince.com/unlocked for 365-day returns, plus free shipping on your order.- Rula: Use Rula to get affordable, high-quality therapy that's actually covered by insurance. Visit https://www.rula.com/Unlocked to get started. You deserve mental healthcare that works with you, not against your budget. #rulapod- Lola: For a limited time, our listeners are getting a huge 40% OFF their entire order. Just head to https://www.LolaBlankets.com and use code Unlocked at checkout for 40% OFF. Wrap yourself in luxury with Lola Blankets.- Progressive: Join the over 28 million drivers who trust Progressive. Visit us at https://www.progressive.com! Thank you to Progressive for sponsoring the show! (Restrictions apply. Not available in all states and situations.)LET'S BE SOCIAL:Follow Savannah Chrisley:Insta: (https://www.instagram.com/SavannahChrisley)TikTok: (https://www.tiktok.com/@SavannahChrisley)X: (https://www.x.com/_itssavannah_)Follow Julie Chrisley:Insta: (https://www.instagram.com/juliechrisley)Facebook: (https://www.facebook.com/JulieChrisley)YouTube: (https://www.youtube.com/@ChrisleyConfessions)Follow The Unlocked Podcast:Insta: (https://www.instagram.com/UnlockedWithSavannah)TikTok: (https://www.tiktok.com/@UnlockedWithSav)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On this month's Q and A episode of The Brad Jensen Show, Craig and I sat down and answered a stacked lineup of questions you all sent in. We kicked things off by diving into GLP medications and the big conversation around sustainability. We talked about who they actually make sense for, the mindset traps people fall into, and what long term success looks like beyond just the scale. From there, we broke down my three rules for life and how those simple principles can anchor you when everything else feels chaotic. We also got into the most overrated exercises in the gym and why the flashy stuff you see on social media rarely moves the needle like people think. Another big part of the discussion was the overlap between fitness and relationships How your habits affect your partner, how communication matters more than macros, and how to stay aligned when you and your significant other might be in different "seasons." We wrapped with practical strategies for balancing a busy life Running businesses, being parents, staying consistent, and not losing your identity in the chaos. And of course, there were a handful of other questions we hit that we left out on purpose You will have to tune in to hear the rest. Next Level Links Nutrition Coaching Free Consultations - Schedule Here Nutrition Coaching - www.becomenextlevel.com Try Thrive Lab Free For One Month - Start Here Order Supplements From Transform Order from Cured Supplement Order from Legion Supplements and get 20% off your first order by using discount code: keynutrition Free Guides: Eating Out Guide - Get The Guide High-Protein Fast Food Orders - Get the Guide Macro Food Options Guide - Get The Guide Join Us On Patreon - Join Here Submit your questions to be featured on our Q&A episodes. Connect with us on Instagram Host Brad Jensen – @thesoberbodybuilder Co-Host Craig Smith - @greatestdaymindset Next Level Nutrition – @mynextlevelnutrition
Sal Di Stefano, a personal trainer for over 20 years and co-host of Mind Pump, joins Max to break down the best foods to boost GLP-1 naturally, what to eat (and the "mouth porn" to avoid) for sustainable fat loss, and how to build a healthier, saner relationship with food, fitness, and your body.15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now!Subscribe to The Genius Life on YouTube! - http://youtube.com/maxlugavereWatch my new documentary Little Empty Boxes - https://www.maxlugavere.com/filmThis episode is proudly sponsored by:JustThrive makes high quality probiotics with mental health in mind. Get 20% your first 90 day bottle when you go to https://justthrivehealth.com/GENIUS and use code GENIUSLIFE at checkout!Momentous holds its products to rigorous quality and purity standards set by the NFL and NBA. I use their creatine and protein regularly. Head to livemomentous.com/genius or use code GENIUS for 35% off your first subscription.Fatty15 provides C15:0, a naturally occurring fatty acid found in full-fat dairy that may support cellular health and longevity—get 15% off at http://fatty15.com/MAX with code MAX!